Haemonetics Corp. (HAE) Tops Q4 EPS by 2c; Guides FY14 EPS Above Views
Haemonetics Corp. (NYSE: HAE) reported Q4 EPS of $0.48, $0.02 better than ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
